|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 16724315.3 (espacenet) (Federated) (European Patent Register), 20160503 | | Patent/reg. no. and date | DK/EP 3291831, 20201230 | | Publication date | 20180314 | | Priority no. and date | EP 15166206, 20150504, US 201562387407 P, 20151223 | | EP pub. no. and date |
EP 3291831 20180314 | | Effective date | | | Applicant/owner | Vakzine Projekt Management GmbH, Mellendorfer Strasse 9
30625 Hannover, DE | | Applicant ref. no. | V51526DK00 | | Inventor | GRODE, Leander, Kranichplatz 4
38110 Braunschweig, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/04 (2006.01) , A61P 13/10 (2006.01) , A61P 35/00 (2006.01) | | Title | Rekombinant mykobakterie som et immunterapeutisk middel til behandling af cancer | | Int. application no. | EP2016059872 | | Int. publication no. | WO2016177717 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
